MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors

NCT02699515 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
114
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merck KGaA, Darmstadt, Germany